Not Yet Recruiting
Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events
NCT07694414
- Conditions
- Immune-Related Adverse Events, Melanoma, Neoplasms, +10 more
- Locations
-
- National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital Herlev, Denmark